Company Ticker News August 17, 2021Warren Buffett's Berkshire Hathaway sold its Biogen stake last quarter - and slashed its pharmaceutical bets 0 0 Share
Company Ticker News August 13, 2021Why Is Biogen Pursuing a New Direction in Alzheimer's Research? 0 0 Share
Company Ticker News August 12, 2021Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs 0 0 Share
Press Release August 2, 2021Biogen Announces Results from Phase 3b NOVA Study Evaluating Every Six-Week Dosing with Natalizumab in Relapsing-Remitting Multiple Sclerosis 0 0 Share
Company Ticker News July 31, 2021Will Biogen Be Able to Move Past the Drama Surrounding Its Alzheimer's Disease Drug? 0 0 Share
Press Release July 29, 2021Should You Invest in This Seemingly Unstoppable Alzheimer's Biotech? 0 0 Share
